Related references
Note: Only part of the references are listed.miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression
Foteini D. Tsikrika et al.
GENES CHROMOSOMES & CANCER (2018)
MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells
Qihui Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Prognostic value of microRNA-155 in human carcinomas: An updated meta analysis
Kangkang Liu et al.
CLINICA CHIMICA ACTA (2018)
miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer
Ning Shao et al.
BMC UROLOGY (2018)
The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients
Pengfei Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
MicroRNAs in the prognosis of triple-negative breast cancer A systematic review and meta-analysis
Lingshuang Lu et al.
MEDICINE (2017)
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
Farah J. Nassar et al.
PHARMACOLOGY & THERAPEUTICS (2017)
MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
Lei Dai et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Expression and prognostic significance of miR-375 and miR-221 in liver cancer
Dafei Xie et al.
ONCOLOGY LETTERS (2017)
Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
Manjula Nakka et al.
ONCOTARGET (2017)
Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
Ling Deng et al.
ONCOTARGET (2017)
miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation
Bailong Li et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Up-regulated miR-221 expression as a molecular diagnostic marker in laryngeal squamous cell carcinoma and its correlation with Apaf-1 expression
Samia Hussein et al.
CANCER BIOMARKERS (2017)
The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer
Seong Lin Teoh et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma
Fan Chen et al.
CANCER BIOMARKERS (2017)
miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway
Bailong Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt
Wenzhuo Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Mir-221/222 are promising targets for innovative anticancer therapy
Maria Teresa Di Martino et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients
Yahui Zhang et al.
TUMOR BIOLOGY (2016)
Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression
Yi Pan et al.
SCIENTIFIC REPORTS (2016)
MicroRNAs as regulatory elements in immune system logic
Arnav Mehta et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma
Zhen Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
Adam E. Frampton et al.
EUROPEAN JOURNAL OF CANCER (2015)
Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
Benedek Gyoengyoesi et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Prognostic Role of MicroRNA-221 in Various Human Malignant Neoplasms: A Meta-Analysis of 20 Related Studies
Jie Yang et al.
PLOS ONE (2014)
Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
Daniel Claudius Vergho et al.
PLOS ONE (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma
Ping Li et al.
MEDICAL SCIENCE MONITOR (2014)
miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases
Ernest K. Amankwah et al.
ASIAN JOURNAL OF ANDROLOGY (2013)
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
N. Falkenberg et al.
BRITISH JOURNAL OF CANCER (2013)
Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer
Fanzhen Hong et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Andreas Karakatsanis et al.
MOLECULAR CARCINOGENESIS (2013)
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis
Jia-Xing Zhang et al.
LANCET ONCOLOGY (2013)
Do microRNA 96, 145 and 221 expressions really aid in the prognosis of prostate carcinoma?
Sung Gu Kang et al.
ASIAN JOURNAL OF ANDROLOGY (2012)
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
Jason A. Hanna et al.
BIOTECHNIQUES (2012)
Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance
K. Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Jipeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs
Konstantinos J. Mavrakis et al.
CELL CYCLE (2011)
Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma
Sun Och Yoon et al.
HUMAN PATHOLOGY (2011)
Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy
Ruihua Zhao et al.
ONKOLOGIE (2011)
MicroRNAs expression signatures are associated with lineage and survival in acute leukemias
Yungui Wang et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma
Hong-Qiang Guo et al.
DISEASE MARKERS (2010)
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
Xing-xiang Pu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Share Paper
